Michael R. Jacobs
1978–2025 年に発表
- 120
- 論文数
- 17,916
- 被引用数
- 82
- h 指数
- 115
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Biochemistry, Genetics and Molecular Biology47.1%
- Medicine40.3%
- Immunology and Microbiology4.6%
- Environmental Science1.8%
- Health Professions1%
- Agricultural and Biological Sciences0.8%
- その他4.4%
トピック
- Antibiotic Resistance in Bacteria16.2%
- Pneumonia and Respiratory Infections7.9%
- Antibiotics Pharmacokinetics and Efficacy7.7%
- Antibiotic Use and Resistance3.7%
- Bacterial Infections and Vaccines2.6%
- Bacterial Identification and Susceptibility Testing2.5%
- その他59.4%
共著者
- Robert A. Bonomo37
- Peter C. Appelbaum26
- Andrea M. Hujer18
- Kristine M. Hujer18
- Saralee Bajaksouzian15
- Caryn E. Good14
- Federico Pérez14
- Barry N. Kreiswirth12
- David van Duin11
- Christopher R. Bethel10
- Krisztina M. Papp‐Wallace10
- Daniel D. Rhoads9
- Steven H. Marshall9
- Andrea Endimiani8
- Mark D. Adams8
- Susan D. Rudin8
- Laura J. Rojas7
- Todd A. Davies7
- Derrick E. Fouts6
- Glenn A. Pankuch6
- Liang Chen6
- Ron Dagan6
- Ayman M. Abdelhamed5
- Magdalena A. Taracila5
全論文
- Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health
著者: Jessica C. Ezeji, Daven K. Sarikonda, Austin Hopperton, Hailey L. Erkkila, Daniel E. Cohen, Sandra P. Martinez, Fabio Cominelli, Tomomi Kuwahara, Armand E. K. Dichosa, Caryn E. Good, Michael R. Jacobs, Mikhail V. Khoretonenko, A.C.M. Veloo, Alexander Rodriguez‐Palacios - Gut Microbes 2021 被引用: 358
- Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
著者: Steven H. Marshall, Andrea M. Hujer, Laura J. Rojas, Krisztina M. Papp‐Wallace, Romney M. Humphries, Brad Spellberg, Kristine M. Hujer, Emma Marshall, Susan D. Rudin, Federico Pérez, Brigid Wilson, Ronald Wasserman, Linda Chikowski, David L. Paterson, Alejandro J. Vila, David van Duin, Barry N. Kreiswirth, Henry F. Chambers, Vance G. Fowler, Michael R. Jacobs, Mark Pulse, Jason Weiss, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2017 被引用: 287
- Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam−β-Lactamase Inhibitor Combination
著者: Krisztina M. Papp‐Wallace, Christopher R. Bethel, J. Caillon, Melissa D. Barnes, G. Potel, Saralee Bajaksouzian, Joseph Rutter, Amokrane Reghal, Stuart Shapiro, Magdalena A. Taracila, Michael R. Jacobs, Robert A. Bonomo, Cédric Jacqueline - Antimicrobial Agents and Chemotherapy 2019 被引用: 118
- Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae
著者: Frank R. DeLeo, Liang Chen, Stephen F. Porcella, Craig Martens, Scott D. Kobayashi, Adeline R. Porter, Kalyan D. Chavda, Michael R. Jacobs, Barun Mathema, Randall J. Olsen, Robert A. Bonomo, James M. Musser, Barry N. Kreiswirth - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 341
- Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
著者: Michael J. Satlin, Liang Chen, Gopi Patel, Angela Gomez‐Simmonds, Gregory Weston, Angela C. Kim, Susan K. Seo, Marnie Rosenthal, Steven J. Sperber, Stephen G. Jenkins, Camille Hamula, Anne‐Catrin Uhlemann, Michael H. Levi, Bettina C. Fries, Yi‐Wei Tang, Stefan Juretschko, Albert Rojtman, Tao Hong, Barun Mathema, Michael R. Jacobs, Thomas J. Walsh, Robert A. Bonomo, Barry N. Kreiswirth - Antimicrobial Agents and Chemotherapy 2017 被引用: 249
- Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network
著者: David van Duin, Federico Pérez, Susan D. Rudin, Eric Cober, Jennifer Hanrahan, Julie T. Ziegler, Raymond Webber, Jacqueline Fox, P Mason, Sandra S. Richter, Marianne Cline, Geraldine S. Hall, Keith S. Kaye, Michael R. Jacobs, Robert C. Kalayjian, Robert A. Salata, Julia A. Segre, Sean Conlan, Scott Evans, Vance G. Fowler, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2014 被引用: 168
- Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance
著者: Meredith S. Wright, Yo Suzuki, Marcus B. Jones, Steven H. Marshall, Susan D. Rudin, David van Duin, Keith S. Kaye, Michael R. Jacobs, Robert A. Bonomo, Mark D. Adams - Antimicrobial Agents and Chemotherapy 2014 被引用: 217
- Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
著者: Melissa D. Barnes, Vijay Kumar, Christopher R. Bethel, Samir H. Moussa, John P. O’Donnell, Joseph Rutter, Caryn E. Good, Kristine M. Hujer, Andrea M. Hujer, Steve H. Marshall, Barry N. Kreiswirth, Sandra S. Richter, Philip N. Rather, Michael R. Jacobs, Krisztina M. Papp‐Wallace, Focco van den Akker, Robert A. Bonomo - mBio 2019 被引用: 117
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
著者: Mark D. Adams, Gabrielle Nickel, Saralee Bajaksouzian, Heather Lavender, A. Rekha Murthy, Michael R. Jacobs, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2009 被引用: 445
- Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
著者: Kristine M. Hujer, Andrea M. Hujer, Edward Hulten, Saralee Bajaksouzian, Jennifer Adams, Curtis J. Donskey, David J. Ecker, Christian Massire, Mark W. Eshoo, Rangarajan Sampath, Jodi M. Thomson, Philip N. Rather, David W. Craft, Joel T. Fishbain, Allesa J. Ewell, Michael R. Jacobs, David L. Paterson, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2006 被引用: 481
- Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
著者: Krisztina M. Papp‐Wallace, Nhu Q. Nguyen, Michael R. Jacobs, Christopher R. Bethel, Melissa D. Barnes, Vijay Kumar, Saralee Bajaksouzian, Susan D. Rudin, Philip N. Rather, Satish Bhavsar, Ravikumar Tadiparthi, Prasad Deshpande, Vijay Patil, Ravindra Yeole, Sachin Bhagwat, Mahesh Patel, Focco van den Akker, Robert A. Bonomo - Journal of Medicinal Chemistry 2018 被引用: 150
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
著者: Melissa D. Barnes, Magdalena A. Taracila, Caryn E. Good, Saralee Bajaksouzian, Laura J. Rojas, David van Duin, Barry N. Kreiswirth, Michael R. Jacobs, Andreas Haldimann, Krisztina M. Papp‐Wallace, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2019 被引用: 55
- ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases
著者: Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, Daniel D. Rhoads, Kristine M. Hujer, Andrea M. Hujer, Tatiana Domitrovic, Susan D. Rudin, Sandra S. Richter, David van Duin, Barry N. Kreiswirth, Chris Greco, Derrick E. Fouts, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2018 被引用: 110
- Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase–4 and New Delhi Metallo-β-Lactamase–1
著者: Mohamad Yasmin, Derrick E. Fouts, Michael R. Jacobs, Hanan Haydar, Steven H. Marshall, Richard C. White, Roshan D’Souza, Thomas P. Lodise, Daniel D. Rhoads, Andrea M. Hujer, Laura J. Rojas, Claudia K. Hoyen, Federico Pérez, Amy Edwards, Robert A. Bonomo - Clinical Infectious Diseases 2019 被引用: 82
- Antimicrobial Resistance inHaemophilus influenzae
著者: SG Tristram, Michael R. Jacobs, Peter C. Appelbaum - Clinical Microbiology Reviews 2007 被引用: 455
- Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters
著者: Michael R. Jacobs - Clinical Microbiology and Infection 2001 被引用: 286
- Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
著者: Robert A. Wise, Janet T. Holbrook, Gerard J. Criner, Sanjay Sethi, Sobharani Rayapudi, Kuladeep Sudini, Elizabeth A. Sugar, Alyce Burke, Rajesh K. Thimmulappa, Anju Singh, Paul Talalay, Jed W. Fahey, Charles S. Berenson, Michael R. Jacobs, Shyam Biswal - PLoS ONE 2016 被引用: 116
- New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis
著者: Meredith S. Wright, Daniel H. Haft, Derek M. Harkins, Federico Pérez, Kristine M. Hujer, Saralee Bajaksouzian, Michael F. Benard, Michael R. Jacobs, Robert A. Bonomo, Mark D. Adams - mBio 2014 被引用: 177
- Comparative Genomic Analysis of KPC-Encoding pKpQIL-Like Plasmids and Their Distribution in New Jersey and New York Hospitals
著者: Liang Chen, Kalyan D. Chavda, Roberto G. Melano, Michael R. Jacobs, Brian Koll, Tao Hong, Albert Rojtman, Michael H. Levi, Robert A. Bonomo, Barry N. Kreiswirth - Antimicrobial Agents and Chemotherapy 2014 被引用: 110
- A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.
著者: Balaji Veeraraghavan, Eunjeong Shin, Yamuna Devi Bakthavatchalam, Abi Manesh, Dilip Dubey, Carlo Tascini, Magdalena A. Taracila, Andrea M. Hujer, Michael R. Jacobs, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2025 被引用: 25
- Pneumococcal Capsular Switching: A Historical Perspective
著者: Kelly L. Wyres, Lotte Lambertsen, Nicholas J. Croucher, Lesley McGee, Anne von Gottberg, Jenniffer Linares, Michael R. Jacobs, Karl G. Kristinsson, Bernard Beall, Keith P. Klugman, Julian Parkhill, Regine Hakenbeck, Stephen D. Bentley, Angela B. Brueggemann - The Journal of Infectious Diseases 2012 被引用: 184
- Drug-resistant Streptococcus pneumoniae: rational antibiotic choices
著者: Michael R. Jacobs - The American Journal of Medicine 1999 被引用: 82
- Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam
著者: María F. Mojica, Krisztina M. Papp‐Wallace, Magdalena A. Taracila, Melissa D. Barnes, Joseph Rutter, Michael R. Jacobs, John J. LiPuma, Thomas J. Walsh, Alejandro J. Vila, Robert A. Bonomo - Antimicrobial Agents and Chemotherapy 2017 被引用: 75
- ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
著者: Alexander G. Mathioudakis, Fekri Abroug, Àlvar Agustí, Sachin Ananth, Per Bakke, Κonstantinos Bartziokas, Bianca Beghé, András Bikov, Thomas Bradbury, Guy Brusselle, Cordula Cadus, Courtney Coleman, Marco Contoli, Alexandru Corlăteanu, Olga Corlateanu, Gerard J. Criner, Balázs Csoma, Alexander Emelyanov, Rosa Faner, Gustavo Fernandez Romero, Zeineb Hammouda, Péter Horváth, Arturo Huerta Garcia, Michael R. Jacobs, Christine Jenkins, Guy Joos, Olga Kharevich, Κonstantinos Κostikas, Elena Lapteva, Zsófia Lázár, Jörg D. Leuppi, Carol Liddle, John Linnell, Alejandra López-Giraldo, Vanessa M. McDonald, Rune Nielsen, Alberto Papi, Isabel Saraiva, Galina Sergeeva, Agni Sioutkou, Pradeesh Sivapalan, Elizabeth Stovold, Hao Wang, Fuqiang Wen, Janelle Yorke, Paula Williamson, Jørgen Vestbo, Jens‐Ulrik Stæhr Jensen - European Respiratory Journal 2021 被引用: 56
